The early detection of cancer can significantly reduce cancer mortality and saves lives. Thus,
a great deal of effort has been devoted to the exploration of new technologies to detect early …

Advances in bioinformatics, genomics, proteomics, and metabolomics have facilitated the
development of novel anticancer agents that have decreased side effects and increased …

Cancer is a major global health burden and poor survival rates can be attributed to lack of
early diagnosis and limited access to timely and standard treatments. Significant progress …

Long non-coding RNAs (lncRNAs) comprise a diverse class of RNA transcripts> 200
nucleotides in length with limited protein-coding potential. In addition to their possible role in …

Specific and sensitive non‐invasive biomarkers for the detection of human epithelial
malignancies are urgently required to reduce the worldwide morbidity and mortality caused …

The detection of nonsmall cell lung cancer (NSCLC) at an early stage presents a daunting
challenge due to the lack of a specific noninvasive marker. The discovery of microRNAs …

Differently expressed microRNAs (miRNAs) in the plasma of lung adenocarcinoma (LA)
patients might serve as biomarkers for LA detection. MiRNA expression profiling was …

Lung cancer is the leading cause of cancer deaths in worldwide. There are many challenges
to detect early stage lung cancer in accurate, inexpensive, and non-invasive ways. In this …

The expression of biomarkers by lung cancers is useful in the diagnosis and clinical
management of patients with lung cancer. Biomarkers provide insight into histogenesis …

Recent studies have indicated that long non-coding RNAs (lncRNAs) could act as non-
invasive tumor markers in both diagnosis and predicting the prognosis. In this study, we …